Jia Yueting officially enters the field of encryption, leading the investment of $41 million in Qualigen with Faraday Future BlockBeats News: On September 30th, according to official sources, Qualigen Therapeutics, Inc. (NASDAQ: QLGN) announced today the successful completion of a $41 million PIPE financing. This round of financing is led by Faraday Future Intelligent Electronics (NASDAQ: FFAI), with its founder and global co CEO Jia Yueting, CEO Jerry Wang, as well as institutions such as SIGN Foundation, Sequoia Capital (US, India, and China), IDG, and Circle participating. Faraday Future has invested $30 million to acquire Qualigen common stock and preferred stock, accounting for approximately 55% of the total equity after financing. Jia Yueting personally invested about 4 million US dollars and voluntarily locked up his position for two years, with a shareholding ratio of about 7%. The company plans to use most of its funds to expand into new cryptocurrency businesses. This financing marks a key milestone for Qualigen's strategic transformation towards Web3 and encryption, and the company plans to rename itself as CXC10. In the future, while maintaining the existing business foundation, we will focus on building encryption businesses with three major growth engines and six core products: ·C10 Value Anchoring System: Establishing value benchmarks through C10 digital asset libraries, C10 indices, and potential C10 ETFs ·DeAI intelligent agent: launches AI encrypted trading assistant BesTrade, connecting users with value discovery ·RWA and Ecological Token: Issuance of C10 stablecoin and "AI+crypto" dual bridge RWA product, connecting traditional assets with Web3 The company aims to become a top US listed company that connects Web2 and Web3, AI and encryption fields, and pioneer a new paradigm of combining AI, encryption and traditional economy. With this round of financing, Jerry Wang will serve as co CEO, Jia Yueting as chief advisor, and Faraday Future CFO Koti Meka will also serve as Qualigen CFO.